Current Liabilities Alterar Data
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
ALKERMES USD 503.11M 15.92M 2023-09
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
Amgen USD 18.39B 1.44B 2023-12
Arrowhead Research USD 63.72M 41.73M 2023-12
Biogen USD 3.43B 1.59B 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Cara Therapeutics USD 22.88M 2.58M 2023-09
Clal Biotechnology ILS 2.91M 173K 2022-12
Compugen USD 10.38M 425K 2023-09
CSL USD 4.61B 278.2M 2023-06
Cytokinetics USD 102.68M 24.96M 2023-12
Enanta Pharmaceuticals USD 62.79M 5.4M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
Grifols EUR 2.03B 148.07M 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Heron Therapeutics USD 79.74M 6.98M 2023-09
Insmed USD 225.63M 28.9M 2023-12
Ligand Pharmaceuticals USD 16.78M 1.06M 2023-12
MannKind USD 104.12M 7.75M 2023-12
Merck EUR 8.68B 161M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Acorda Therapeutics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.